MDRNA is a biotechnology company focused on the development and commercialization
of therapeutic products based on RNA interference (RNAi). We are building a
broad, flexible and cutting-edge...
Arrowhead Research Corporation is a publicly-traded nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is building value for...
Panomics is a privately-held life science company focused on parallel quantitative biology (PQB) a platform of reagents and products that enable the multiplex measurement of molecular events, such as...
We are rapidly gaining a reputation as the “go-to” firm that large pharmaceutical and biotechnology companies come to when encountering obstacles in developing new biological drugs. Our...
RNA interference (RNAi) is a powerful strategy for suppressing gene expression in a sequence-specific manner. This strategy offers new potential opportunities for treating various diseases by...
http://www.azonano.com/article.aspx?ArticleID=2387 | 16 Sep 2009
The incorporation of nanomaterials in surface coatings can provide long-term abrasion resistance without significantly effecting optical clarity, gloss, color or physical properties. NanoDur alumina...
http://www.azonano.com/article.aspx?ArticleID=1642 | 18 Jul 2006
Research and Markets has announced the addition of Jain PharmaBiotech's new
- Technologies, Markets and Companies" to their offering.
RNA interference (RNAi) or gene silencing...
http://www.azonano.com/news.aspx?newsID=9841 | 10 Feb 2009
Reportlinker.com announces that a new market research report is available in its catalogue: RNAi Technologies and Global...
http://www.azonano.com/news.aspx?newsID=28529 | 18 Oct 2013
Small pieces of synthetic RNA trigger a RNA interference (RNAi) response that holds great therapeutic potential to treat a number of diseases, especially cancer and pandemic viruses. The problem is...
http://www.azonano.com/news.aspx?newsID=31533 | 18 Nov 2014
a leading life science company and member of The RNAi Consortium (TRC), proudly
welcomes the Memorial Sloan-Kettering Cancer Center to the RNAi
Partnership Program. The...
http://www.azonano.com/news.aspx?newsID=8137 | 15 Oct 2008